Doctor profile · Federal record
Dr. NATALIE KING, NP
Adult Health Nurse Practitioner (CMS: NURSE PRACTITIONER) · RICHMOND, IN
- NPI 1396122735
- Accepts Medicare
- 11 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 5 locations .
- Primary practice
-
1050 REID PKWY STE 300
RICHMOND, IN 473741155
(765) 935-8941
fax (765) 935-8578 - Additional location
-
1154 S State Road 1 Ste 1
Cambridge City, IN 473279513
(765) 478-6108 - Additional location
-
1475 E State Road 44 Ste 3
Connersville, IN 473310219
(765) 827-5690 - Additional location
-
386 Symmes Center Dr Ste 1
Winchester, IN 473949402
(765) 584-6600 - Additional location
-
1101 Jackson St Ste A
Greenville, OH 453311396
(765) 935-8641 - Mailing address
-
1100 REID PKWY, PAYOR ENROLLMENT
RICHMOND, IN 473741157
Show 2 more locations
Credentials & registration
- NPI registered
- May 2015 — 11 yrs on file
- Profile last updated
- December 2, 2025
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 363LA2200X — NUCC code
- State license (1)
- Indiana #71005726A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1396122735. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,505
Distinct HCPCS
7
Medicare allowed
$139,301
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 2,340 | 37 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 625 | 361 | $102 | |
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 563 | 314 | $3 | |
83036 |
Hemoglobin a1c level | 503 | 290 | $9 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 368 | 210 | $28 | |
96372 |
Injection of drug or substance under skin or into muscle | 53 | 44 | $11 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 53 | 42 | $73 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 236. This provider delivers 19× the peer median.Open Payments
Industry payments received
All-time total
$1,700
Transactions
96
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 29 | $372.76 | |
| Corcept Therapeutics | 11 | $171.00 | |
| Insulet Corporation | 9 | $141.97 | |
| CeQur Corporation | 1 | $139.78 | |
| Lilly USA, LLC | 9 | $134.87 | |
| Xeris Pharmaceuticals, Inc. | 7 | $132.35 | |
| Abbott Laboratories | 3 | $107.97 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $79.37 | |
| Tandem Diabetes Care, Inc. | 5 | $78.83 | |
| AstraZeneca Pharmaceuticals LP | 5 | $77.41 | |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59.48 | |
| Radius Health, Inc. | 2 | $37.14 | |
| BETA BIONICS, INC. | 3 | $32.77 | |
| RECORDATI_RARE_DISEASES_INC. | 2 | $31.59 | |
| Amgen Inc. | 2 | $31.46 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,659
Patients
582
Total drug cost
$1,485,988
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 271 | 90 | $485,347 |
| Levothyroxine Sodium | Generic | 180 | 60 | $2,982 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 173 | 69 | $2,579 |
| Mounjaro (Tirzepatide) | Brand | 159 | 40 | $194,248 |
| Metformin Hcl | Generic | 154 | 48 | $1,631 |
| Jardiance (Empagliflozin) | Brand | 139 | 39 | $172,110 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 82 | 36 | $59,079 |
| Atorvastatin Calcium | Generic | 72 | 25 | $945 |
| Tresiba Flextouch U-100 (Insulin Degludec) | Brand | 72 | 37 | $50,442 |
| Humalog Kwikpen U-100 (Insulin Lispro) | Brand | 69 | 25 | $120,632 |